Legal Updates & Publications
At Drew & Napier, we provide legal updates and publications on the latest legal and regulatory developments that matter to our clients and friends.
You are encouraged to look through our online legal updates and publications by using the search function below.
Note: The legal updates and publications on this site are for general information only and should not be considered legal advice.
Legal Updates
Search results: 416 results
-
17 June 2026
The chapter provides insights into local regulatory framework, foreign ownership restrictions and licensing requirements. The chapter also summarises the key emerging trends and hot topics in communications and media regulations in Singapore, among o...
More
Articles Authored
-
03 June 2026
The chapter provides an overview of data protection & cybersecurity laws and regulations in Singapore, and highlights relevant provisions and guidelines in respect of pertinent and emergent issues internationally (e.g. monitoring and profiling of ind...
More
Articles Authored
-
29 May 2026
The chapter covers the latest legal developments surrounding the use of artificial intelligence, including in areas such as IP ownership/protection, antitrust/competition laws, data protection and online harms.
More
Articles Authored
-
26 May 2026
The chapter provides an overview of the law and enforcement regime relating to cartels, key issues in relation to enforcement policy and investigations, amongst others.
More
Articles Authored
-
25 May 2026
This chapter offers a practical, at-a-glance reference into patent litigation and patent office procedures in Singapore, including patent enforcement proceedings; scope and ownership of patents; defences; remedies; licensing; and patent office proce...
More
Articles Authored
-
22 May 2026
ASPEC+ is a new option under the existing ASPEC framework. Developed under Singapore’s leadership as Chair of the ASEAN Patents Task Force, ASPEC+ is designed to deliver more closely harmonised patent examination outcomes within committed timelines. ...
More
Articles Authored
-
22 May 2026
In biotech, early filing does not automatically lead to strong protection. In fact, filing too early can sometimes produce the opposite result. An application may secure a priority date, yet still fail to deliver meaningful patent coverage if the und...
More
Articles Authored
-
22 May 2026
“Skinny labelling” sits at the intersection of two competing policy objectives: enabling timely generic entry for unpatented indications, while preserving meaningful exclusivity for second medical use innovation. While the regulatory logic is relativ...
More
Articles Authored
-
22 May 2026
Seemingly small errors can have large downstream implications in patent examination and enforcement. It is best to check the specification to ensure that everything is in order before filing the application at the Registry.
More
Articles Authored
-
22 May 2026
In a Chapter 18A listing, the patent portfolio serves as a practical indicator of business fundamentals, together with clinical data and regulatory progress. Investors consider whether the science is genuinely novel, whether competitors can design ar...
More
Articles Authored